Search clinical trials for: 200 mg SPN-812
Total 1947 results
-
Supernus Pharmaceuticals, Inc.CompletedAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
Supernus Pharmaceuticals, Inc.Completed
-
Supernus Pharmaceuticals, Inc.Completed
-
Supernus Pharmaceuticals, Inc.Completed
-
Supernus Pharmaceuticals, Inc.Completed
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)WithdrawnOpioid Use DisorderUnited States
-
Supernus Pharmaceuticals, Inc.CompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Supernus Pharmaceuticals, Inc.CompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Supernus Pharmaceuticals, Inc.RecruitingAttention-Deficit/Hyperactivity DisorderUnited States
-
Kowa Research Institute, Inc.CompletedHyperlipidemiaUnited States
-
Ilkos Therapeutic Inc.CompletedVenous Leg UlcerSpain, Hungary, Canada, United States, Brazil, Argentina, Austria, Czechia, Italy, Poland, Slovakia
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Completed
-
Yuhan CorporationCompleted
-
CVI PharmaceuticalsUnknown
-
Zhejiang Hisun Pharmaceutical Co. Ltd.UnknownEarly Rheumatoid ArthritisChina
-
Valenta Pharm JSCCompletedInfluenza | Viral Respiratory Infection | Acute Viral Upper Respiratory InfectionsRussian Federation
-
PHARMENTERPRISES LLCCompletedInfluenza | Acute Respiratory Viral InfectionsRussian Federation
-
Forest LaboratoriesCompletedHealthyUnited States
-
Bial - Portela C S.A.CompletedParkinson's DiseaseSwitzerland
-
Supernus Pharmaceuticals, Inc.CompletedConduct Disorder | Attention Deficit Disorder With HyperactivityUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedAsthma; Allergic RhinitisChina
-
NP TherapeuticsCompletedCovid19 | Healthy VolunteersRussian Federation
-
GlaxoSmithKlineCompletedPsoriasisGermany, United Kingdom
-
Eisai Co., Ltd.CompletedCoronary Artery DiseaseJapan
-
Supernus Pharmaceuticals, Inc.CompletedAttention-Deficit/Hyperactivity Disorder (ADHD)United States, Puerto Rico
-
University of CalgaryNot yet recruitingChronic Migraine
-
Supernus Pharmaceuticals, Inc.TerminatedAttention Deficit Hyperactivity DisorderUnited States
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive Aggression Comorbid With ADHDUnited States
-
Galapagos NVCompletedHealthyUnited Kingdom
-
Zhejiang Genfleet Therapeutics Co., Ltd.Completed
-
Galapagos NVCompletedCystic FibrosisSpain, United Kingdom, United States, Netherlands, Belgium, Serbia
-
GlaxoSmithKlineTerminatedSystemic Lupus ErythematosusEstonia, Germany, South Africa, Peru, Sweden, France, Korea, Republic of, Hong Kong, Spain, Romania, Czechia, Argentina, Chile, Hungary, Greece, Poland
-
VIVUS LLCCompleted
-
Bausch Health Americas, Inc.CompletedRheumatoid ArthritisUnited States
-
Kowa Research Institute, Inc.CompletedDyslipidemiaUnited States
-
GlaxoSmithKlineCompleted
-
Innovative Molecules GmbHRecruiting
-
Procter and GambleCompletedOsteoarthritis, KneeHungary, United Kingdom
-
Transposon Therapeutics, Inc.Active, not recruitingProgressive Supranuclear PalsyUnited States
-
Boehringer IngelheimCompleted
-
OrthoTrophix, IncCompleted
-
Impax Laboratories, LLCCompletedIdiopathic Parkinson's DiseaseUnited States
-
PHARMENTERPRISES LLCCompleted
-
University of California, San FranciscoSan Francisco VA Health Care SystemCompletedAlcohol Use DisorderUnited States
-
Basilea PharmaceuticaCompletedUrothelial CarcinomaUnited Kingdom, Korea, Republic of, Italy, Canada, France, Spain, Germany, United States, Hungary, Australia, Poland, Switzerland, Czechia, Austria
-
Yungjin Pharm. Co., Ltd.CompletedMELAS Syndrome | Mitochondrial Respiratory Chain DeficienciesKorea, Republic of
-
TaiRx, Inc.CompletedAdvanced CancerTaiwan
-
Pain TherapeuticsNational Institute on Aging (NIA)CompletedAlzheimer Disease | Alzheimer Disease, Early OnsetUnited States
-
Boehringer IngelheimCompletedPsoriasisUnited States, Canada, Germany